-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
-
Summary
-
Guided Therapeutics Inc quarterly/annual Depreciation history and growth rate from Q1 2014 to Q1 2024.
- Guided Therapeutics Inc Depreciation for the quarter ending March 31, 2024 was $2K, unchanged year-over-year.
- Guided Therapeutics Inc annual Depreciation for 2023 was $9K, a 125% increase from 2022.
- Guided Therapeutics Inc annual Depreciation for 2022 was $4K, a 300% increase from 2021.
- Guided Therapeutics Inc annual Depreciation for 2021 was $1K.
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)